APIC expert urges mask-wearing in LTC, despite guidance switch
By
Alicia Lasek
Oct 04, 2022
Despite a recent shift in CDC guidance, now is not the right time for long-term care providers to relax masking and other source control use, says infection preventionist Deb Burdsall of APIC.
Clinical briefs for Tuesday, Oct. 4
By
Alicia Lasek
Oct 04, 2022
McKnight’s announces new Pinnacle Awards program to recognize industry veterans … Supreme Court turns away challenge to U.S. vaccine rule for health workers … Instacart’s new initiative aims to...
CDC: Two booster shots cut severe COVID risk in nursing home residents by 74 percent
By
Alicia Lasek
Oct 03, 2022
Nursing home residents who received a second mRNA booster shot during omicron were much less likely to suffer severe COVID-19 outcomes than their peers who received only one dose, a new study shows.
Multimorbidity may up seniors’ dementia risk by 63 percent over 15 years
By
Alicia Lasek
Oct 03, 2022
Identifying high-risk disease clusters could help clinicians to better target patients for dementia care, researchers say.
New prognostic tool supports end-of-life discussions for dementia patients, families: study
By
Alicia Lasek
Oct 03, 2022
A prognostic tool that estimates mortality risk may help clinicians to guide discussions about treatment decisions and advance care planning, investigators say.
Clinical briefs for Monday, Oct. 3
By
Alicia Lasek
Oct 03, 2022
Florida’s “deadliest storm” puts LTC providers and home care operators to the test … Assessment expert offers advice on handling the wave of new ICD coding changes … FDA approves much-needed...
AHCA: To avoid new COVID testing citations, heed manufacturers’ use instructions
By
Alicia Lasek
Sep 30, 2022
LTC facilities must adhere to manufacturers’ use instructions after a CMS change in enforcement discretion for COVID testing, the advocate says.
More seniors getting flu, shingles and pneumonia shots, but disparities remain
By
Alicia Lasek
Sep 30, 2022
Vaccination discrepancies among older demographic groups are likely due to care access, hesitancy and cost, the AARP says.
Too early to celebrate? Alzheimer’s drug trial success leaves questions
By
Alicia Lasek
Sep 30, 2022
News that Alzheimer’s drug lecanemab has reduced cognitive decline by 27% is receiving measured responses from prescribers as they await further data.
Clinical briefs for Friday, Sept. 30
By
Alicia Lasek
Sep 30, 2022
Medicare to cover medically tailored meals? It would under Biden plan … Tufts scientists to test effect of nutritious shake on memory in seniors … AHCA summarizes CDC’s flu vax reporting requirements...